ENFN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
Today's Volume	256 905
Average Volume	423 958
Market Cap	835.80M
EPS	$0 ( 2024-03-12 )
Next earnings date	( $0.0400 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	132.86
ATR14	$0.00800 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-05	Movchan Oleg	Buy	149 701	Class A Common Stock
2024-03-05	Movchan Oleg	Buy	100 000	Class A Common Stock
2024-03-01	Movchan Oleg	Buy	13 887	Class A Common Stock
2024-03-01	Movchan Oleg	Sell	4 069	Class A Common Stock
2024-03-01	Pawar Neal	Buy	144 176	Class A Common Stock

INSIDER POWER
10.68
Last 99 transactions
Buy: 4 242 931 \| Sell: 3 488 116

Volume Correlation

Long: -0.07 (neutral)

Short: 0.40 (neutral)

Signal:(56.464) Neutral

Enfusion, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Enfusion, Inc. Correlation - Currency/Commodity

0.31
( neutral )

0.01
( neutral )

0.00
( neutral )

0.12
( neutral )

0.00
( neutral )

-0.13
( neutral )

Enfusion, Inc. Financials

Annual	2023
Revenue:	$174.54M
Gross Profit:	$116.89M (66.97 %)
EPS:	$0.0718

Q4	2023
Revenue:	$46.49M
Gross Profit:	$30.86M (66.39 %)
EPS:	$0.00720

Q3	2023
Revenue:	$44.36M
Gross Profit:	$29.85M (67.29 %)
EPS:	$0.0208

Q2	2023
Revenue:	$42.72M
Gross Profit:	$28.51M (66.74 %)
EPS:	$0.00710

Financial Reports:

No articles found.

Enfusion, Inc.

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.